A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection
Rituximab is a B-lymphocyte depleting agent that is used to treat hematological malignancies and autoimmune diseases. Recently, it has gained interest as an immunomodulatory agent in renal transplantation. This systematic review evaluates the evidence for its use in the treatment of acute and chroni...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2017
|